Monopar Therapeutics (MNPR)
Score window: May. 30, 2025 to May. 29, 2026
| Date | Form | Sentiment | Urgency | Summary | Open |
|---|---|---|---|---|---|
| Sep. 5, 2025 | CORRESP | Neutral/Informational | Moderate | Monopar Therapeutics Inc. has submitted a request to the SEC to accelerate the effective date of its registration statement on Form S-3 to September 9, 2025. The company acknowled… | Read Filing EDGAR |
| Sep. 4, 2025 | UPLOAD | Neutral/Informational | Low | The SEC has communicated to Monopar Therapeutics that they will not review the company's registration statement filed on August 29, 2025. The letter emphasizes that the responsibi… | Read Filing EDGAR |
| Jul. 25, 2025 | UPLOAD | Neutral/Informational | Low | The SEC has completed its review of Monopar Therapeutics Inc.'s Form 10-K for the fiscal year ended December 31, 2024. The correspondence emphasizes that the responsibility for th… | Read Filing EDGAR |
| Jul. 22, 2025 | CORRESP | Neutral/Informational | Moderate | Monopar Therapeutics has responded to comments from the SEC regarding their Form 10-K for the fiscal year ended December 31, 2024. The SEC raised concerns about the inclusion of t… | Read Filing EDGAR |
| Jul. 16, 2025 | UPLOAD | Concern from SEC | High | The SEC has reviewed Monopar Therapeutics' Form 10-K for the fiscal year ended December 31, 2024, and has issued several comments requiring clarification and additional informatio… | Read Filing EDGAR |